Information Journal Paper
APA:
Copy. (2017). Efficacy and safety of omalizumab in Japanese and Korean patients with refractory chronic spontaneous urticaria. JOURNAL OF DERMATOLOGICAL SCIENCE, 87(-), 70-78. SID. https://sid.ir/paper/771877/en
Vancouver:
Copy. Efficacy and safety of omalizumab in Japanese and Korean patients with refractory chronic spontaneous urticaria. JOURNAL OF DERMATOLOGICAL SCIENCE[Internet]. 2017;87(-):70-78. Available from: https://sid.ir/paper/771877/en
IEEE:
Copy, “Efficacy and safety of omalizumab in Japanese and Korean patients with refractory chronic spontaneous urticaria,” JOURNAL OF DERMATOLOGICAL SCIENCE, vol. 87, no. -, pp. 70–78, 2017, [Online]. Available: https://sid.ir/paper/771877/en